Evaluation of Internet-based Cognitive Behavioral Self-help Treatments for People With Psychosis
EviBaS
1 other identifier
interventional
101
2 countries
2
Brief Summary
Schizophrenia is a severe mental disorder which is accompanied by an enormous individual and societal burden. Despite established efficacy of cognitive behavioral therapy for psychosis (CBTp), its dissemination into routine mental health care remains poor. National regulations such as the National Institute for Health and Care Excellence (NICE) guideline in the United Kingdom recommend that CBTp should be offered to every person with psychotic symptoms, but more than 50% do not receive even a single session of CBTp. In Germany, CBTp is virtually not represented in the psychotherapy health service. Internet-based cognitive behavioral therapy (CBT) in a self-help format has been proven feasible and effective in anxiety and depressive disorders. Recently, Internet-based (self-help) interventions are also deployed via smartphone apps. The feasibility of Internet-based treatments for people with schizophrenia is well documented for Internet-based interventions (e.g., medication management) and also reported for smartphone interventions. However, there is a dearth of empirical studies precluding a conclusive picture. As far as the investigators know, there is only one study encompassing 90 participants with psychosis that investigated an Internet-based intervention with symptom-specific, cognitive behavioral interventions, which is from the investigators' research group. The unique features of the proposed project are 1) the first-time evaluation of a symptom-oriented, CBTp-based self-help treatment for people with psychotic symptoms via Internet, enhanced with smartphone assistance. The study is set up as randomized controlled trial (RCT) with active treatment versus a wait-list control group. It evaluates a combined Internet-based guided self-help treatment for persecutory ideation and auditory verbal hallucinations. The active treatment condition consists of access to a self-help website including regular written electronic contact with a guide and access to smartphone-based interactive worksheets (apps). The trials combine the low-threshold advantages of an online approach (e.g., anonymity) with the virtues of a clinical trial (e.g., symptom assessment and diagnostic verification via Interview). The primary outcome measure is the Positive and Negative Syndrome Scale (PANSS). Secondary outcome measures include self-reported symptom measures (Paranoia Checklist; Beliefs About Voices Questionnaire revised), completion rates, drop-out from the intervention, general symptomatology, side-effects, and client satisfaction. The project will help to answer the empirical question whether CBTp-based interventions in a purely Internet-based self-help format are effective. Positive findings would pave the way for an easy-to-access treatment option for patients with psychotic symptoms who currently are deprived of psychotherapeutic treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable schizophrenia
Started Dec 2016
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 16, 2016
CompletedFirst Posted
Study publicly available on registry
November 28, 2016
CompletedStudy Start
First participant enrolled
December 6, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 16, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
April 16, 2019
CompletedMay 9, 2019
May 1, 2019
2.4 years
November 16, 2016
May 8, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Positive and Negative Syndrome Scale (PANSS)
Kay et al. (1987); clinician administered
Change in PANSS from pre-intervention to post-intervention (i.e. between 1 and 7 days after completion of the last module)
Secondary Outcomes (5)
Paranoia Checklist (PC)
Change in PC from pre-intervention to post-intervention (i.e. between 1 and 7 days after completion of the last module)
Launay-Slade Hallucination Scale (LSHS)
Change in LSHS from pre-intervention to post-intervention (i.e. between 1 and 7 days after completion of the last module)
Patient Health Questionnaire (PHQ-9)
Change in PHQ-9 from pre-intervention to post-intervention (i.e. between 1 and 7 days after completion of the last module)
Incongruence Scale (INK)
Change in INK from pre-intervention to post-intervention (i.e. between 1 and 7 days after completion of the last module)
Quality of life (WHO-QOL)
Change in WHO-QOL from pre-intervention to post-intervention (i.e. between 1 and 7 days after completion of the last module)
Study Arms (2)
Internet-based guided self-help
EXPERIMENTALInternet-based, guided, CBT-oriented self-help treatment for persecutory ideation and auditory verbal hallucinations with access to a self-help website including regular written electronic contact with a guide and access to smartphone-based interactive worksheets (8 weeks)
Wait-List
NO INTERVENTIONWait-list control group (8 weeks)
Interventions
The self-help program includes sessions regarding (1) cognitive model, (2) sleep hygiene, (3) mindfulness, (4) meta-cognition, (5) coping with voice hearing, (6) persecutory ideation, (7) worrying, (8) self-esteem, (9) depression, (10) social competence, and (11) relapse prevention.
Eligibility Criteria
You may qualify if:
- Electronic informed consent
- Internet access
- Adequate command of the German language
- PANSS Suspiciousness/persecution \>= 3 AND/OR PANSS hallucinations \>=3
- Diagnosis of schizophrenia, schizoaffective disorder or delusional disorder
- Concurrent psychopharmacological treatment
You may not qualify if:
- Acute suicidality
- Acute risk of endangering others
- No emergency plan (with is formulated during the telephone interview)
- Disease of the central nervous system with need for treatment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Bernlead
- Universitätsklinikum Hamburg-Eppendorfcollaborator
Study Sites (2)
University Medical Center Hamburg-Eppendorf
Hamburg, 20246, Germany
University of Bern
Bern, 3012, Switzerland
Related Publications (3)
Westermann S, Ruegg N, Ludtke T, Moritz S, Berger T. Internet-based self-help for psychosis: Findings from a randomized controlled trial. J Consult Clin Psychol. 2020 Oct;88(10):937-950. doi: 10.1037/ccp0000602. Epub 2020 Aug 13.
PMID: 32790453DERIVEDLudtke T, Platow-Kohlschein H, Ruegg N, Berger T, Moritz S, Westermann S. Mindfulness Mediates the Effect of a Psychological Online Intervention for Psychosis on Self-Reported Hallucinations: A Secondary Analysis of Voice Hearers From the EviBaS Trial. Front Psychiatry. 2020 Apr 3;11:228. doi: 10.3389/fpsyt.2020.00228. eCollection 2020.
PMID: 32308631DERIVEDRuegg N, Moritz S, Berger T, Ludtke T, Westermann S. An internet-based intervention for people with psychosis (EviBaS): study protocol for a randomized controlled trial. BMC Psychiatry. 2018 Apr 13;18(1):102. doi: 10.1186/s12888-018-1644-8.
PMID: 29653532DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Stefan Westermann, Dr
University of Bern
- PRINCIPAL INVESTIGATOR
Steffen Moritz, Prof. Dr.
Universitätsklinikum Hamburg-Eppendorf
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 16, 2016
First Posted
November 28, 2016
Study Start
December 6, 2016
Primary Completion
April 16, 2019
Study Completion
April 16, 2019
Last Updated
May 9, 2019
Record last verified: 2019-05